Cardiawave
is headquartered in Paris, Île-de-France. Olivier Pierron is the CEO of Cardiawave. Cardiawave has received a total of $8.2M in funding. Cardiawave has 1 followers on Owler.Cardiawave
is headquartered in Paris, Île-de-France. Olivier Pierron is the CEO of Cardiawave. Cardiawave has received a total of $8.2M in funding. Cardiawave has 1 followers on Owler.
News
Jun 15, 2026
GlobalNewswire
Press Release: Cardiawave : Cardiawave Announces First Routine Treatments Performed with Valvosoft Following CE Mark Approval and Accelerates Its Deployment
Dec 05, 2025
Medical Device Network
Cardiawave: Cardiawave secures CE mark for ultrasound aortic stenosis therapy
May 22, 2025
FinanzNachrichten
Cardiawave: Cardiawave SA: Cardiawave Announces Positive 12-Month Results from Its "Valvosoft FIM Study" and "Valvosoft Pivotal Study" for the Treatment of Severe Symptomatic Aortic Stenosis (sSAS)
Oct 28, 2024
FinanzNachrichten
Cardiawave: Cardiawave SA: Cardiawave Announces Positive Six-Month Data from Valvosoft Pivotal Study at Transcatheter Cardiovascular Therapeutics (TCT) Conference
Apr 05, 2024
StreetInsider
Cardiawave: Cardiawave is presenting the 30-day follow-up results from its "Valvosoft Pivotal Study" on the treatment of severe symptomatic aortic valve stenosis
Nov 15, 2023
FinanzNachrichten
Cardiawave: Cardiawave Announces the Publication in The Lancet of First-In-Human Clinical Studies Results With 40 Aortic Stenosis Patients Treated With Its Innovative Non-invasive Ultrasound Therapy (NIUT)
Nov 15, 2023
Zephyr Net
Cardiawave: Cardiawave lays next steps for ultrasound therapy after positive FIH trial
Apr 06, 2023
Medical Product Outsourcing
Cardiawave: Cardiawave Granted Three New Patents
Feb 13, 2023
Life Care News
Cardiawave: Cardiawave Granted 3 New Patents Extending Its Intellectual Property Protection for Its Technology in the United States
Jun 14, 2022
Business Wire
Press Release: Cardiawave : Cardiawave Confirms the Safety of VALVOSOFT its Non-Invasive Ultrasound Treatment for Aortic Stenosis